Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock · CUSIP: 75382E109
Event date: 2025-01-31
- Filing-level shares
- 2,932,399
- Percent of class
- 2.22%
- The Vanguard Group
Shares: 2,932,399 · Class: 2.22%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000350
- Form type
- SCHEDULE 13G/A
- Filer
- RAPT Therapeutics, Inc.
- CIK
- CIK 1673772
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership